bioRxivCell Biology
Uev1A counteracts oncogenic Ras stimuli in both polyploid and diploid cells
Qi ZhangiD, Yunfeng Wang, Xueli Fu, Ziguang WangiD, Yang ZhangiD, Lizhong Yan, Yuejia WangiD, Muhan YangiD, Dan SongiD, Ruixing ZhangiD, Hongru ZhangiD, Shian WuiD, Shaowei ZhaoiD
- Citations
- 0
Abstract
Oncogenic Ras is known to induce DNA replication stress, leading to cellular senescence or death. In contrast, we found that it can also trigger polyploid Drosophila ovarian nurse cells to die by inducing aberrant division stress. To explore intrinsic protective mechanisms against this specific form of cellular stress, here we conducted a genome-wide genetic screen and identified the E2 enzyme Uev1A as a key protector. Reducing its expression levels exacerbates the nurse cell death induced by oncogenic Ras, while overexpressing it or its human homologs, UBE2V1 and UBE2V2, mitigates this effect. Although Uev1A is primarily known for its non-proteolytic functions, our studies demonstrate that it collaborates with the E3 APC/C complex to mediate the proteasomal degradation of Cyclin A, a key cyclin that drives cell division. Furthermore, Uev1A and UBE2V1/2 also counteract oncogenic Ras-driven tumorigenesis in diploid cells, suppressing the overgrowth of germline tumors in Drosophila and human colorectal tumor xenografts in nude mice, respectively. Remarkably, elevated expression levels of UBE2V1/2 correlate with improved survival rates in human colorectal cancer patients harboring oncogenic KRAS mutations, indicating that their upregulation could represent a promising therapeutic strategy.
- organism: Drosophila
- organism: human
- assay: proteomics
- assay: spatial transcriptomics
- research focus: cancer & tumor microenvironment
- research focus: cell signaling & trafficking
- research focus: gene regulatory network inference
- approach: genetic perturbation / CRISPR
- approach: experimental assay
- approach: biophysical modeling
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Oncogenic H-Ras Signaling Differentially Targets Replicative and Specialized DNA Polymerases for Depletion
W.-c. Tsao, R. Buj-gomez, … K. A. Eckert·bioRxiv·Jul 1, 2020
- Oncogenic KRAS cells use Wnt signalling and cell dormancy to override homeostatic cell elimination mechanisms in adult pancreas.
B. Salvador-Barbero, M. Alatsatianos, … C. Hogan·bioRxiv·Feb 13, 2024
- Oncogenic RAS sensitizes cells to drug-induced replication stress via transcriptional silencing of P53
H. A. Segeren, E. A. van Liere, … B. Westendorp·bioRxiv·Jun 14, 2021
- Oncogenic Ras deregulates cell-substrate interactions during mitotic rounding and respreading to alter cell division orientation
S. Ganguli, T. Wyatt, … H. Matthews·bioRxiv·Jan 12, 2023
- RAS specific protease Induces Irreversible Growth Arrest via p27 in several KRAS Mutant Colorectal Cancer cell lines
C. K. Stubbs, M. Biancucci, … K. J. F. Satchell·bioRxiv·Dec 8, 2020
- Modulating the unfolded protein response: Impacts of radiation on the response of prostate cancer cells to ONC201
F. Amoroso, K. Glass, … I. Mills·Scientific ReportsPeer-reviewed·Feb 19, 2021